<DOC>
<DOCNO>
EP-0002916
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
A23K-1/16 C07D-493/00 A61K-31/365 A61P-33/00 A61K-31/40 <main>A61K-31/335</main> A61K-31/35 C07D-493/20 A61P-33/10 A23K-1/17 C07D-493/22 
</IPC-CLASSIFICATIONS>
<TITLE>
a milbemycin compound or a mixture thereof for use in the treatment of helminthic infections and anthelmintic compositions containing such compounds.
</TITLE>
<APPLICANT>
merck & co inc us <sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
putter irving<sep>putter, irving<sep>putter, irvingbox 436r.d. no. 1 martinsville new jersey 08836us<sep>putter, irving<sep>putter, irvingbox 436r.d. no. 1 martinsville new jersey 08836us<sep>
</INVENTOR>
<ABSTRACT>
the milbemycins are a known series of macrolides,  which are disclosed as having insecticidal activity.  these  compounds have been discovered to have substantial  anthelmintic activity and in accordance with the invention  are used in the treatment of helmintic infections.  compositions  containing the milbemycin compounds as the active  ingredient thereof are also disclosed.  
</ABSTRACT>
</TEXT>
</DOC>
